Zetterberg, Henrik
University of Wisconsin–Madison · Sahlgrenska University Hospital · UCL Queen Square Institute of Neurology · University College London · Indian Institute of Science Bangalore · University of Gothenburg
309 papers on CoChatORCID 0000-0003-3930-4354
Most cited papers
- Verified
One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury
Clarke, G. J. B., Skandsen, T., Zetterberg, H., Einarsen, C. E., Feyling, C., Follestad, T., Vik, A., Blennow, K., & Håberg, A. K. (2021) · Frontiers in Neurology
Traumatic Brain Injury ResearchTraumatic Brain Injury and Neurovascular Disturbances
Cited by 43
- Verified
Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women
Gustavsson, J., Mehlig, K., Leander, K., Strandhagen, E., Björck, L., Thelle, D. S., Lissner, L., Blennow, K., Zetterberg, H., & Nyberg, F. (2012) · Atherosclerosis
Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology
Cited by 41
- Verified
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
Sogorb-Esteve, A., Nilsson, J., Swift, I. J., Heller, C., Bocchetta, M., Russell, L. L., Peakman, G., Convery, R. S., van Swieten, J. C., Seelaar, H., et al. (2022) · Alzheimer's Research & Therapy
Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments
Cited by 39
- Verified
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Kruse, N., Persson, S., Alcolea, D., Bahl, J. M. C., Baldeiras, I., Capello, E., Chiasserini, D., Bocchio Chiavetto, L., Emersic, A., Engelborghs, S., et al. (2015) · Neurobiology of Aging
Parkinson's Disease Mechanisms and TreatmentsClinical Laboratory Practices and Quality Control
Cited by 38
- Verified
Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease
Jensen, C. S., Portelius, E., Høgh, P., Wermuth, L., Blennow, K., Zetterberg, H., Hasselbalch, S. G., & Simonsen, A. H. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 36
- Verified
A blood‐based multi‐pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups
Jiang, Y., Uhm, H., Ip, F. C., Ouyang, L., Lo, R. M. N., Cheng, E. Y. L., Cao, X., Tan, C. M. C., Law, B. C. H., Ortiz‐Romero, P., et al. (2024) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 36
- Verified
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer’s continuum
Salvadó, G., Milà-Alomà, M., Shekari, M., Ashton, N. J., Operto, G., Falcon, C., Cacciaglia, R., Minguillon, C., Fauria, K., Niñerola-Baizán, A., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 36
- Verified
Blood Biomarkers for Alzheimer’s Disease: Much Promise, Cautious Progress
Keshavan, A., Heslegrave, A., Zetterberg, H., & Schott, J. M. (2017) · Molecular Diagnosis & Therapy
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 34
- Verified
Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients
Sajjad, M. U., Blennow, K., Knapskog, A. B., Idland, A.-V., Chaudhry, F. A., Wyller, T. B., Zetterberg, H., & Watne, L. O. (2020) · Journal of Alzheimer’s Disease
Intensive Care Unit Cognitive DisordersAnesthesia and Neurotoxicity Research
Cited by 34
- Verified
Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
Falgàs, N., Ruiz‐Peris, M., Pérez‐Millan, A., Sala‐Llonch, R., Antonell, A., Balasa, M., Borrego‐Écija, S., Ramos‐Campoy, O., Augé, J. M., Castellví, M., et al. (2020) · Human Brain Mapping
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 32
- Verified
TREM2 expression in the brain and biological fluids in prion diseases
Diaz-Lucena, D., Kruse, N., Thüne, K., Schmitz, M., Villar-Piqué, A., da Cunha, J. E. G., Hermann, P., López-Pérez, Ó., Andrés-Benito, P., Ladogana, A., et al. (2021) · Acta Neuropathologica
Prion Diseases and Protein MisfoldingNeuroinflammation and Neurodegeneration Mechanisms
Cited by 32
- Verified
The Nairobi Declaration—reducing the burden of dementia in low- and middle-income countries (LMICs): declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs
Maestre, G., Carrillo, M., Kalaria, R., Acosta, D., Adams, L., Adoukonou, T., Akinwande, K., Akinyemi, J., Akinyemi, R., Akpa, O., et al. (2023) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchMental Health Treatment and Access
Cited by 31
- Verified
Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia
Johansson, A., Hampel, H., Faltraco, F., Buerger, K., Minthon, L., Bogdanovic, N., Sjögren, M., Zetterberg, H., Forsell, L., Lilius, L., et al. (2003) · Neuroscience Letters
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 31
- Verified
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Blennow, K., Stomrud, E., Zetterberg, H., Borlinghaus, N., Corradini, V., Manuilova, E., Müller-Hübner, L., Quevenco, F.-C., Rutz, S., & Hansson, O. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM)
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 30
- Verified
Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study
Vrillon, A., Ashton, N. J., Karikari, T. K., Götze, K., Cognat, E., Dumurgier, J., Lilamand, M., Zetterberg, H., Blennow, K., & Paquet, C. (2024) · Journal of Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 28
- Verified
Altered T-cell reactivity in the early stages of Alzheimer's disease
Rickenbach, C., Mallone, A., Häusle, L., Frei, L., Seiter, S., Sparano, C., Kirabali, T., Blennow, K., Zetterberg, H., Ferretti, M. T., et al. (2025) · Brain
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 27
- Verified
CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology
Cousins, K. A. Q., Arezoumandan, S., Shellikeri, S., Ohm, D., Shaw, L. M., Grossman, M., Wolk, D., McMillan, C. T., Chen-Plotkin, A., Lee, E., et al. (2022) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 25
- Verified
Semagacestat's fall: where next for AD therapies?
Blennow, K., Zetterberg, H., Haass, C., & Finucane, T. (2013) · Nature Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 24
- Verified
Genetic Mapping of APP and Amyloid-β Biology Modulation by Trisomy 21
Mumford, P., Tosh, J., Anderle, S., Gkanatsiou Wikberg, E., Lau, G., Noy, S., Cleverley, K., Saito, T., Saido, T. C., Yu, E., et al. (2022) · The Journal of Neuroscience
Alzheimer's disease research and treatmentsDown syndrome and intellectual disability research
Cited by 22
- Verified
Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study
Jonsson, M., Zetterberg, H., Rolstad, S., Edman, A., Gouw, A. A., Bjerke, M., Lind, K., Blennow, K., Pantoni, L., Inzitari, D., et al. (2012) · Dementia and Geriatric Cognitive Disorders
Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research
Cited by 22
- Verified
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Johansson, P., Almqvist, E. G., Wallin, A., Johansson, J.-O., Andreasson, U., Blennow, K., Zetterberg, H., & Svensson, J. (2017) · PLOS ONE
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 20
- Verified
Amyloid precursor protein processing in human neurons with an allelic series of the PSEN1 intron 4 deletion mutation and total presenilin-1 knockout.
Arber, C., Villegas-Llerena, C., Toombs, J., Pocock, J. M., Ryan, N. S., Fox, N. C., Zetterberg, H., Hardy, J., & Wray, S. (2019) · Brain Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 19
- Verified
The role of neurofilament light in genetic frontotemporal lobar degeneration
Zetterberg, H., Teunissen, C., van Swieten, J., Kuhle, J., Boxer, A., Rohrer, J. D., Mitic, L., Nicholson, A. M., Pearlman, R., McCaughey, S. M., et al. (2022) · Brain Communications
Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research
Cited by 19
- Verified
Evaluation of two plasma‐based proteotyping assays against APOE ε4 genotyping in a memory clinic setting: The Gothenburg H70 Clinical Studies
Dittrich, A., Blennow, K., Tan, K., Benedet, A. L., Skoog, I., Höglund, K., Ashton, N. J., Zetterberg, H., & Kern, S. (2025) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free